Condition: Stimulant Use · Human Immunodeficiency Virus (HIV) · Depression · Sponsor: Wake Forest University Health Sciences
The purpose of this research is to understand how chronic stress affects the way our brain and immune systems function, and in turn how this affects the way people feel, think, and behave. By learning more about how these processes work, the hope is to be able to develop better treatments to help with problems like depression and substance use. This study is intended for individuals that are HIV positive, currently taking prescription antiretroviral medications, and use stimulants. Through this intervention, the aim is to determine if this positive affect intervention can lead to reductions in stimulant use and depressed mood.
This description comes directly from the study's public registry record.
Christina S Meade, PhD · 336-716-0695 · cmeade@wakehealth.edu
Sheri L Towe, PhD · 336-716-4331 · stowe@wakehealth.edu
Always discuss trial participation with your own doctor first.
| Wake Forest University School of Medicine | Winston-Salem, North Carolina, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06814275